{
  "created_at": "2020-11-18T03:56:42.000Z",
  "updated_at": "2021-01-06T08:25:12.208Z",
  "id": "619a0991-58bd-4891-82dc-b80fdc2e5f49",
  "labels": "current-affairs,2020-11-19",
  "question": "Which Indian company has commenced phase III trials of Covid-19 vaccine 'Covaxin'?",
  "option1": "Biocon",
  "option2": "Bharat Biotech",
  "option3": "Serum Institute of India",
  "option4": "Dr Reddys Lab",
  "option5": "",
  "answer": "Bharat Biotech",
  "explanation": "Bharat Biotech has recently commenced phase III trials of Covid-19 vaccine Covaxin, which is Indiaâ€™s first indigenous Covid-19 vaccine candidate.<br />Another Hyderabad-based pharma company Biological E Ltd has begun its Phase I-II trials of its Covid-19 vaccine. The Phase III trials will be conducted in partnership with ICMR and will involve around 26,000 volunteers across India."
}